One of the most pressing challenges associated with SARS-CoV-2 treatment is the
emergence of new variants that may be more transmissible, cause more severe disease, or …

Lung infections in Influenza-Like Illness (ILI) are triggered by a variety of respiratory viruses.
All human pandemics have been caused by the members of two major virus families …

Inhalation phage therapy is proposed as a replacement approach for antibiotics in the
treatment of pulmonary bacterial infections. This study investigates phage therapy on …

Coronavirus disease 2019 (COVID-19) is a worldwide public health and economic threat,
and virus variation amplifies the difficulty in epidemic prevention and control. The structure of …

The recent coronavirus disease 2019 (COVID-19) pandemic was caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is characterized by …

SARS-CoV-2 as a zoonotic virus has significantly affected daily life and social behavior
since its outbreak in late 2019. The concerns over its transmission through different media …

The L84S mutation has been observed frequently in the ORF8 protein of SARS-CoV-2,
which is an accessory protein involved in various important functions such as virus …

The SARS-CoV-2 ORF7b protein has drawn attention for its potential role in viral
pathogenesis, but its structural details and lateral membrane associations remain elusive. In …

SARS-CoV-2 remains a major global public health concern. Antibody waning and immune
escape variant emergence necessitate the development of next generation vaccines that …

The outbreak of the novel coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused great harm to all …